NYSEAMERICAN:MLSS

Milestone Scientific Stock Forecast, Price & News

$1.93
-0.02 (-1.03 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.93
$2.01
50-Day Range
$1.47
$2.31
52-Week Range
$1.30
$4.85
Volume585,120 shs
Average Volume609,214 shs
Market Capitalization$128.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32
30 days | 90 days | 365 days | Advanced Chart
Receive MLSS News and Ratings via Email

Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter.


Milestone Scientific logo

About Milestone Scientific

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; and Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific, Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.15 out of 5 stars

Medical Sector

1019th out of 2,100 stocks

Surgical Appliances & Supplies Industry

20th out of 40 stocks

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Milestone Scientific (NYSEAMERICAN:MLSS) Frequently Asked Questions

Is Milestone Scientific a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Scientific in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Milestone Scientific stock.
View analyst ratings for Milestone Scientific
or view top-rated stocks.

What stocks does MarketBeat like better than Milestone Scientific?

Wall Street analysts have given Milestone Scientific a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Milestone Scientific wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Milestone Scientific's next earnings date?

Milestone Scientific is scheduled to release its next quarterly earnings announcement on Friday, August 13th 2021.
View our earnings forecast for Milestone Scientific
.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) posted its earnings results on Monday, May, 17th. The medical instruments supplier reported ($0.01) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.03) by $0.02. Milestone Scientific had a negative net margin of 123.64% and a negative trailing twelve-month return on equity of 39.49%.
View Milestone Scientific's earnings history
.

What guidance has Milestone Scientific issued on next quarter's earnings?

Milestone Scientific issued an update on its first quarter 2021 earnings guidance on Monday, May, 17th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $2.90 million-$2.90 million, compared to the consensus revenue estimate of $2.01 million.

What price target have analysts set for MLSS?

2 brokerages have issued 12 month price objectives for Milestone Scientific's stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Milestone Scientific's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 107.3% from the stock's current price.
View analysts' price targets for Milestone Scientific
or view top-rated stocks among Wall Street analysts.

Who are Milestone Scientific's key executives?

Milestone Scientific's management team includes the following people:
  • Mr. Leonard A. Osser, Founder & Vice Chairman (Age 74, Pay $1.02M)
  • Mr. Jan Adriaan Haverhals, Pres (Age 59, Pay $358.53k)
  • Mr. James McAvinn, Sr. VP of Sales & Marketing

Who are some of Milestone Scientific's key competitors?

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include Fortinet (FTNT), Cellectar Biosciences (CLRB), Eldorado Gold (EGO), Advanced Micro Devices (AMD), Plug Power (PLUG), Vista Gold (VGZ), Ampio Pharmaceuticals (AMPE), Amarin (AMRN), Avadel Pharmaceuticals (AVDL) and Enterprise Products Partners (EPD).

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."

Who are Milestone Scientific's major shareholders?

Milestone Scientific's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.72%), Geode Capital Management LLC (1.04%), Northern Trust Corp (0.73%), EAM Investors LLC (0.47%), Nuveen Asset Management LLC (0.30%) and Bank of New York Mellon Corp (0.19%). Company insiders that own Milestone Scientific stock include Giandomenico Trombetta, Joseph D'agostino and Leonard Osser.
View institutional ownership trends for Milestone Scientific
.

Which major investors are selling Milestone Scientific stock?

MLSS stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Mercer Global Advisors Inc. ADV, New York State Common Retirement Fund, and Nuveen Asset Management LLC. Company insiders that have sold Milestone Scientific company stock in the last year include Giandomenico Trombetta, Joseph D'agostino, and Leonard Osser.
View insider buying and selling activity for Milestone Scientific
or view top insider-selling stocks.

Which major investors are buying Milestone Scientific stock?

MLSS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., EAM Investors LLC, Geode Capital Management LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, Paloma Partners Management Co, Private Advisor Group LLC, and Cubist Systematic Strategies LLC.
View insider buying and selling activity for Milestone Scientific
or or view top insider-buying stocks.

How do I buy shares of Milestone Scientific?

Shares of MLSS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Milestone Scientific's stock price today?

One share of MLSS stock can currently be purchased for approximately $1.93.

How much money does Milestone Scientific make?

Milestone Scientific has a market capitalization of $128.84 million and generates $5.44 million in revenue each year. The medical instruments supplier earns $-7,340,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

How many employees does Milestone Scientific have?

Milestone Scientific employs 19 workers across the globe.

What is Milestone Scientific's official website?

The official website for Milestone Scientific is www.milesci.com.

Where are Milestone Scientific's headquarters?

Milestone Scientific is headquartered at 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States.

How can I contact Milestone Scientific?

Milestone Scientific's mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier can be reached via phone at (973) 535-2717.


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.